Melanopsin retinal ganglion cell loss in Alzheimer disease

Annals of Neurology

Volumn 79, Issue 1, 2016, Pages 90-109

  La Morgia, Chiara ^a,b   Ross Cisneros, Fred N ^c   Koronyo, Yosef ^c   Hannibal, Jens ^e   Gallassi, Roberto ^a,b   Cantalupo, Gaetano ^f   Sambati, Luisa ^a,b   Pan, Billy X ^g   Tozer, Kevin R ^g   Barboni, Piero ^h   Provini, Federica ^a,b   Avanzini, Pietro ⁱ   Carbonelli, Michele ^a   Pelosi, Annalisa ⁱ   Chui, Helena ^g   Liguori, Rocco ^a,b   Baruzzi, Agostino ^a,b   Koronyo Hamaoui, Maya ^d   Sadun, Alfredo A ^c,j   Carelli, Valerio ^a,b  

^a BELLARIA HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c DOHENY EYE INSTITUTE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF VERONA   (Italy)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h Studio Oculistico d'Azeglio   (Italy)

ⁱ UNIVERSITY OF PARMA   (Italy)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MELANOPSIN; SCOTOPSIN;

ACTIMETRY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL LOSS; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; NERVE FIBER; NEUROPATHOLOGY; OPTIC NERVE; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; RETINAL NERVE FIBER LAYER THICKNESS; SLEEP; VERY ELDERLY; AXON; CHRONOBIOLOGY DISORDERS; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ACTIGRAPHY; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AXONS; CHRONOBIOLOGY DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPTIC NERVE; RETINAL GANGLION CELLS; ROD OPSINS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84956576175     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24548     Document Type: Article

References (75)

1. Querfurth HW, LaFerla FM,. Alzheimer's disease. N Engl J Med 2010; 362: 329-344.
2. Wu YH, Swaab DF,. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med 2007; 8: 623-636.
3. Hatfield CF, Herbert J, van Someren EJ, et al.; Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004; 127: 1061-1074.
4. Dowling GA, Burr RL, Van Someren EJ, et al.; Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56: 239-246.
5. Swaab DF, Fliers E, Partiman TS,. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985; 342: 37-44.
6. Stopa EG, Volicer L, Kuo-Leblanc V, et al.; Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 1999; 58: 29-39.
7. Harper DG, Stopa EG, Kuo-Leblanc V, et al.; Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain 2008; 131: 1609-1617.
8. Dowling GA, Hubbard EM, Mastick J, et al.; Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr 2005; 17: 221-236.
9. Hinton DR, Sadun AA, Blanks JC, Miller CA,. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986; 315: 485-487.
10. Blanks JC, Hinton DR, Sadun AA, Miller CA,. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 1989; 501: 364-372.
11. Sadun AA, Bassi CJ,. Optic nerve damage in Alzheimer's disease. Ophthalmology 1990; 97: 9-17.
12. Iseri PK, Altinaş O, Tokay T, Yüksel N,. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26: 18-24.
13. Berisha F, Feke GT, Trempe CL, et al.; Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48: 2285-2289.
14. Paquet C, Boissonnot M, Roger F, et al.; Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007; 420: 97-99.
15. Lu Y, Li Z, Zhang X, et al.; Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett 2010; 480: 69-72.
16. Kesler A, Vakhapova V, Korczyn AD, et al.; Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011; 113: 523-526.
17. Moschos MM, Markopoulos I, Chatziralli I, et al.; Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Curr Alzheimer Res 2012; 9: 782-788.
18. Kirbas S, Turkyilmaz K, Anlar O, et al.; Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 2013; 33: 58-61.
19. Marziani E, Pomati S, Ramolfo P, et al.; Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2013; 54: 5953-5958.
20. Kromer R, Serbecic N, Hausner L, et al.; Detection of retinal nerve fiber layer defects in Alzheimer's disease using SD-OCT. Front Psychiatry 2014; 5: 22.
21. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, et al.; Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 2011; 54 (suppl 1): S204-S217.
22. Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ,. Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease. Neuroreport 2011; 22: 623-627.
23. Tsai Y, Lu B, Ljubimov AV, et al.; Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest Ophthalmol Vis Sci 2014; 55: 523-534.
24. Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M,. Alzheimer's disease in the retina: imaging retinal Aβ plaques for early diagnosis and therapy assessment. Neurodegener Dis 2012; 10: 285-293.
25. Ning A, Cui J, To E, et al.; Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 2008; 49: 5136-5143.
26. Perez SE, Lumayag S, Kovacs B, et al.; Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Invest Ophthalmol Vis Sci 2009; 50: 793-800.
27. Chiu K, Chan TF, Wu A, et al.; Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? Age (Dordr) 2012; 34: 633-649.
28. Hattar S, Liao HW, Takao M, et al.; Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002; 295: 1065-1070.
29. Berson DM, Dunn FA, Takao M,. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002; 295: 1070-1073.
30. Sand A, Schmidt TM, Kofuji P,. Diverse types of ganglion cell photoreceptors in the mammalian retina. Prog Retin Eye Res 2012; 31: 287-302.
31. Schmidt TM, Chen SK, Hattar S,. Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions. Trends Neurosci 2011; 34: 572-580.
32. Sadun AA, Schaechter JD, Smith LE,. A retinohypothalamic pathway in man: light mediation of circadian rhythms. Brain Res 1984; 302: 371-377.
33. Hannibal J,. Neurotransmitters of the retino-hypothalamic tract. Cell Tissue Res 2002; 309: 73-88.
34. Hannibal J, Fahrenkrug J,. Neuronal input pathways to the brain's biological clock and their functional significance. Adv Anat Embryol Cell Biol 2006; 182: 1-71.
35. Semo M, Peirson S, Lupi D, et al.; Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice. Eur J Neurosci 2003; 17: 1793-1801.
36. La Morgia C, Ross-Cisneros FN, Sadun AA, et al.; Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain 2010; 133: 2426-2438.
37. Feigl B, Mattes D, Thomas R, Zele AJ,. Intrinsically photosensitive (melanopsin) retinal ganglion cell function in glaucoma. Invest Ophthalmol Vis Sci 2011; 52: 4362-4367.
38. La Morgia C, Ross-Cisneros FN, Hannibal J, et al.; Melanopsin-expressing retinal ganglion cells: implications for human diseases. Vision Res 2011; 51: 296-302.
39. McKhann G, Drachman D, Folstein M, et al.; Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
40. Folstein MF, Folstein SE, McHugh PR,. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
41. Barboni P, Savini G, Valentino ML, et al.; Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005; 112: 120-126.
42. Witting W, Kwa IH, Eikelenboom P, et al.; Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 1990; 27: 563-572.
43. Van Someren EJ, Swaab DF, Colenda CC, et al.; Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 1999; 16: 505-518.
44. Hyman BT, Trojanowski JQ,. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 1095-1097.
45. Mirra SS, Heyman A, McKeel D, et al.; The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
46. Braak H, Braak E,. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995; 16: 271-278.
47. Hannibal J, Hindersson P, Ostergaard J, et al.; Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. Invest Ophthalmol Vis Sci 2004; 45: 4202-4209.
48. Hannibal J, Kankipati L, Strang CE, et al.; Central projections of intrinsically photosensitive retinal ganglion cells in the macaque monkey. J Comp Neurol 2014; 522: 2231-2248.
49. Dacey DM, Liao HW, Peterson BB, et al.; Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 2005; 433: 749-754.
50. Coggeshall RE, Lekan HA,. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 1996;364:6-15; erratum 1996; 369: 162.
51. Saper CB,. Any way you cut it: a new journal policy for the use of unbiased counting methods. J Comp Neurol 1996; 364: 5.
52. Guillery RW,. On counting and counting errors. J Comp Neurol 2002; 447: 1-7.
53. Montine TJ, Phelps CH, Beach TG, et al.; National Institute on Aging; Alzheimer's Association. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123: 1-11.
54. Pirici D, Mogoanta L, Kumar-Singh S, et al.; Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype. J Histochem Cytochem 2009; 57: 567-575.
55. Faul F, Erdfelder E, Lang AG, Buchner A,. G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191.
56. Trick GL, Trick LR, Morris P, Wolf M,. Visual field loss in senile dementia of the Alzheimer's type. Neurology 1995; 45: 68-74.
57. Quigley HA, Dunkelberger GR, Green WR,. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988; 95: 357-363.
58. Sadun AA, Johnson B, Miao M,. Axon caliber populations in the human optic nerve: changes with age and disease. In:, Ishikawa S, Mukuno K, Uga S, Van Dalen JTW, eds. Highlights in neuro-ophthalmology: proceedings of the sixth meeting of the International Neuro-Ophthalmology Society (INOS), Hakone, Japan, 8-14 June 1986. Amsterdam, the Netherlands: Aeolus, 1987: 15-20.
59. Bayer AU, Ferrari F, Erb C,. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002; 47: 165-168.
60. Johnson BM, Miao M, Sadun AA,. Age-related decline of human optic nerve axon populations. Age 1987; 10: 5-9.
61. Budenz DL, Anderson DR, Varma R, et al.; Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology 2007; 114: 1046-1052.
62. Hooghiemstra AM, Eggermont LH, Scheltens P, et al.; The Rest-Activity Rhythm and Physical Activity in Early-Onset Dementia. Alzheimer Dis Assoc Disord 2015; 29: 45-49.
63. Satlin A, Volicer L, Stopa EG, Harper D,. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol Aging 1995; 16: 765-771.
64. Van Someren EJ, Hagebeuk EE, Lijzenga C, et al.; Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 1996; 40: 259-270.
65. Volicer L, Harper DG, Manning BC, et al.; Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 2001; 158: 704-711.
66. Prinz PN, Larsen LH, Moe KE, Vitiello MV,. EEG markers of early Alzheimer's disease in computer selected tonic REM sleep. Electroencephalogr Clin Neurophysiol 1992; 83: 36-43.
67. Moe KE, Vitiello MV, Larsen LH, Prinz PN,. Symposium: Cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res 1995; 4: 15-20.
68. Wu YH, Fischer DF, Kalsbeek A, et al.; Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". FASEB J 2006; 20: 1874-1876.
69. Moura AL, Nagy BV, La Morgia C, et al.; The pupil light reflex in Leber's hereditary optic neuropathy: evidence for preservation of melanopsin-expressing retinal ganglion cells. Invest Ophthalmol Vis Sci 2013; 54: 4471-4477.
70. Fotiou DF, Stergiou V, Tsiptsios D, et al.; Cholinergic deficiency in Alzheimer's and Parkinson's disease: evaluation with pupillometry. Int J Psychophysiol 2009; 73: 143-149.
71. Schön C, Hoffmann NA, Ochs SM, et al.; Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One 2012; 7: e53547.
72. Lim AS, Ellison BA, Wang JL, et al.; Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease. Brain 2014; 137: 2847-2861.
73. Forbes D, Blake CM, Thiessen EJ, et al.; Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev 2014; 2: CD003946.
74. Tranah GJ, Blackwell T, Stone KL, et al,; SOF Research Group. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 2011; 70: 722-732.
75. Froy O,. Circadian rhythms, aging, and life span in mammals. Physiology (Bethesda) 2011; 26: 225-235.